Re: Remdesivir for the treatment of COVID-19 by Lee et al.

Beccacece, Alessia; Ascoli Bartoli, Tommaso; Nicastri, Emanuele

Re: Remdesivir for the treatment of COVID-19 by Lee et al.

Beccacece, Alessia; Ascoli Bartoli, Tommaso; Nicastri, Emanuele.

Afiliación

Beccacece A; National Institute for Infectious Diseases Lazzaro, Spallanzani Institute for Hospitalization and Care Scientific, Clinical, Division of Infectious Diseases, Italy. Electronic address: alessia.beccacece@inmi.it.
Ascoli Bartoli T; National Institute for Infectious Diseases, Lazzaro Spallanzani Institute for Hospitalization and Care Scientific, Clinical Department, Italy.
Nicastri E; National Institute for Infectious Diseases, Lazzaro Spallanzani Institute for Hospitalization and Care Scientific, Clinical Department, Italy; INMI "L. Spallanzani", Clinical Department, Italy.

Clin Microbiol Infect ; 29(1): 114, 2023 01.

Article en En | MEDLINE | ID: mdl-36206865

Asunto(s)

COVID-19; Humanos; Tratamiento Farmacológico de COVID-19; Antivirales/uso terapéutico; SARS-CoV-2

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 Límite: Humans Idioma: En Revista: Clin Microbiol Infect Asunto de la revista: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Año: 2023 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google